Liu et al[37] revealed that lncRNA HCP5 is highly expressed in pancreatic cancer and the development of gemcitabine-resistant pancreatic cancer cells encompassing the processes of proliferation, invasive, migration, cell apoptosis, and autophagy through the miR-214-3p–HDGF axis. This evidence concerns the gene HCP5 and familial pancreatic carcinoma.